IRIS
GOZZO, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.658
AS - Asia 1.514
EU - Europa 1.135
SA - Sud America 171
AF - Africa 166
OC - Oceania 6
Totale 4.650
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.626
SG - Singapore 678
CN - Cina 574
RU - Federazione Russa 531
IT - Italia 273
IE - Irlanda 163
BR - Brasile 155
KR - Corea 149
CI - Costa d'Avorio 79
SN - Senegal 39
VN - Vietnam 36
NL - Olanda 31
IN - India 29
FI - Finlandia 25
GB - Regno Unito 24
CA - Canada 22
BJ - Benin 19
SE - Svezia 18
DE - Germania 12
UA - Ucraina 12
ZA - Sudafrica 12
ES - Italia 11
JP - Giappone 11
BE - Belgio 10
PL - Polonia 10
BD - Bangladesh 9
NG - Nigeria 8
AR - Argentina 7
MX - Messico 7
AU - Australia 6
TR - Turchia 6
AT - Austria 3
PK - Pakistan 3
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HK - Hong Kong 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
NO - Norvegia 2
OM - Oman 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
EG - Egitto 1
FR - Francia 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
IS - Islanda 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MW - Malawi 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 4.650
Salva come PNG Salva come JPEG
Città #
Singapore 390
Santa Clara 385
Dallas 345
Hefei 311
Moscow 230
Dublin 162
Seoul 149
Ashburn 140
Chicago 86
Boardman 80
Abidjan 79
Chandler 64
Beijing 55
Los Angeles 52
Civitanova Marche 39
Dakar 39
Catania 34
Rome 30
New York 28
Amsterdam 25
Cotonou 19
Washington 19
Stockholm 18
São Paulo 15
Palermo 14
Ho Chi Minh City 13
Milan 12
Buffalo 11
Lappeenranta 11
Pune 11
Brussels 10
Montreal 10
Tokyo 10
Warsaw 10
Campobasso 9
Abuja 8
Boston 8
Brooklyn 8
Chennai 8
Manchester 8
Phoenix 8
Seattle 8
Cambridge 7
Council Bluffs 7
Hanoi 7
Helsinki 7
Johannesburg 7
Lawrence 7
Rio de Janeiro 7
Andover 6
Denver 6
Poplar 6
Des Moines 5
Jacksonville 5
Munich 5
Orem 5
Assago 4
Assoro 4
Atlanta 4
Augusta 4
Belo Horizonte 4
Bologna 4
Dong Ket 4
Gela 4
Melbourne 4
Milwaukee 4
Reggio Calabria 4
Trento 4
Turku 4
Anápolis 3
Castelraimondo 3
Columbus 3
Espoo 3
Florence 3
Houston 3
Lamezia Terme 3
London 3
Messina 3
Miami 3
Mumbai 3
Piazzola Sul Brenta 3
Querétaro 3
Redondo Beach 3
San Francisco 3
San Giovanni la Punta 3
Secaucus 3
Shenyang 3
The Dalles 3
Adamantina 2
Agawam 2
Ankara 2
Bari 2
Betim 2
Brasília 2
Cabo Frio 2
Caruaru 2
Caxias do Sul 2
Cernusco sul Naviglio 2
Charlotte 2
City of London 2
Totale 3.191
Salva come PNG Salva come JPEG
Nome #
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 146
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 144
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 127
Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure 127
Accesso ai medicinali innovativi per indicazioni neurologiche in Europa: allineamento delle valutazioni di Health Technology Assessment tra i Paesi Europei 126
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 122
Fluoxetine Protects Retinal Ischemic Damage in Mice 120
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 117
Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries 116
EMA: l’ente che vigila sui medicinali che circolano nella Comunità Europea 107
Editorial: Innovation in ocular pharmacology 105
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation 105
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 99
Linking the Price of Cancer Drug Treatments to Their Clinical Value 98
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 92
Flavan-3-ols and Vascular Health: Clinical Evidence and Mechanisms of Action 91
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 91
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 90
Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies 90
Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue 90
Bioequivalence, Drugs with Narrow Therapeutic Index and The Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution 89
Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries 89
AIFA: l’ente che autorizza un nuovo farmaco, una nuova formulazione o una nuova indicazione in Italia 87
Response to Letter to the Editor by Dr. Garattini 86
COVID-19 Disease and Vitamin D: A Mini-Review 86
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review 85
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 84
Sviluppo ed uso dei farmaci: dal laboratorio alla clinica. 84
Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap 84
Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval? 82
Attitude survey of spontaneous adverse drug-reaction reporting by general practitioners in Sicily 80
Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries 78
How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA) 77
Editorial: Innovative treatments for neuro-psychiatric diseases 75
Beyond the budget silo approach: estimating health system sustainability for future dementia drugs 72
OFF-LABEL USE OF MEDICINES: A CLINICAL AND REGULATORY OPPORTUNITYTHE. 40TH CONGRESS OF THE ITALIAN PHARMACOLOGICAL SOCIETY (SIF) 69
Anemia Mediterranea o talassemia: c’è qualcosa per evitare le trasfusioni? 69
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA) 68
Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved? 64
Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence 63
Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota 61
Periodontal Disease and Pregnancy: Correlation with Underweight Birth 59
Obesità e farmaci: quando servono e quali usare 58
Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale Anno 2019. Roma: Agenzia Italiana del Farmaco, 2020. 57
La sclerosi multipla: una malattia invalidante con nuove possibilità di cura 57
Starting Dose Of Non-Vitamin K Antagonist Oral Anticoagulation Agents In Patients With Atrial Fibrillation: Data From Italian Monitoring Registries 57
The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience 56
Scheda informativa Tocilizumab per uso endovenoso nel trattamento di pazienti gravi con COVID-19 55
Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation 55
The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries 53
Towards a European harmonization of health technology assessment recommendations executive paper of European regulatory conference focused on the EU commission proposal to harmonize HTA 52
The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review 50
SARS-Cov-2 Damage on the Nervous System and Mental Health 50
Prevenzione e terapia dell’osteoporosi: quali farmaci sono utili e cosa c’è di nuovo 49
Quali farmaci usare per l’età pediatrica? 49
Più che una speranza, oggi è una certezza la possibilità di ridurre la gravità dell’atrofia muscolare spinale 48
Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei farmaci in Italia. Rapporto Nazionale Anno 2018. Roma: Agenzia Italiana del Farmaco, 2019 45
Phase II, noncomparative, open label, multicenter, study of osimertinib, in patients with locally advanced or metastatic EGFR mutated, T790M undetectable or unknown non-small cell lung cancer (Stage IIIB-IV) after no immediate prior EGFR TKI (OSIRIS study) 43
Asma: vecchi e nuovi farmaci e attenzione al CoViD-19 41
Totale 4.769
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 1 0 1 3 3 5
2021/202275 1 6 3 1 8 5 6 1 10 10 5 19
2022/2023500 8 11 4 10 80 99 31 102 118 1 24 12
2023/2024448 18 58 35 42 26 97 21 39 3 13 62 34
2024/20251.404 19 161 62 64 312 162 71 40 91 110 135 177
2025/20262.307 256 396 409 212 461 573 0 0 0 0 0 0
Totale 4.769